Avadel Pharmaceuticals Plc ADR (AVDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2008 | 12-2007 | 09-2007 | 06-2007 | 03-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,690 | -37,730 | -31,800 | -22,690 | -9,060 |
| Depreciation Amortization | 1,640 | 6,190 | 4,530 | 3,000 | 1,470 |
| Other Working Capital | -3,650 | 1,860 | 620 | -970 | -3,150 |
| Other Operating Activity | 2,320 | 10,440 | 9,050 | 6,380 | 3,260 |
| Operating Cash Flow | $-3,380 | $-19,240 | $-17,600 | $-14,280 | $-7,480 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,180 | -11,220 | -11,180 | -6,170 | -3,190 |
| Other Investing Activity | 7,800 | -2,010 | 770 | 1,190 | 2,820 |
| Investing Cash Flow | $6,620 | $-13,230 | $-10,410 | $-4,980 | $-370 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -70 | 3,020 | 3,110 | 3,190 | 20 |
| Financing Cash Flow | $-70 | $3,020 | $3,110 | $3,190 | $20 |
| Exchange Rate Effect | 2,120 | 3,930 | 2,610 | 1,060 | 450 |
| Beginning Cash Position | 26,310 | 51,820 | 51,820 | 51,820 | 51,820 |
| End Cash Position | 31,600 | 26,310 | 29,530 | 36,820 | 44,440 |
| Net Cash Flow | $5,290 | $-25,510 | $-22,280 | $-15,000 | $-7,380 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,380 | -19,240 | -17,600 | -14,280 | -7,480 |
| Free Cash Flow | -3,380 | -19,240 | -17,600 | -14,280 | -7,480 |